Brain- and heart-type fatty acid-binding proteins in the brain: tissue distribution and clinical utility.

M.M.A.L. Pelsers*, T. Hanhoff, D. van der Voort, B. Arts, M. Peters, R.W.H.M. Ponds, A. Honig, W. Rudzinski, F. Spener, J.R. de Kruijk, A. Twijnstra, W.T. Hermens, P.P.C.A. Menheere, J.F. Glatz

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Background: Detection of brain injury by serum markers is not a standard procedure in clinical practice, although several proteins, such as S100B, neuron-specific enolase (NSE), myelin basic protein, and glial fibrillary acidic protein, show promising results. We investigated the tissue distribution of brain- and heart-type fatty acid-binding proteins (B-FABP and H-FABP) in segments of the human brain and the potential of either protein to serve as plasma marker for diagnosis of brain injury. Methods: B-FABP and H-FABP were measured immunochemically in autopsy samples of the brain (n = 6) and in serum samples from (a) patients with mild traumatic brain injury (MTBI; n = 130) and (b) depressed patients undergoing bilateral electroconvulsive therapy (ECT; n = 14). The protein markers S100B and NSE were measured for comparison. Reference values of B-FABP and H-FABP were established in healthy individuals (n = 92). Results: The frontal, temporal, and occipital lobes, the striatum, the pons, and the cerebellum had different tissue concentrations of B-FABP and of H-FABP. B-FABP ranged from 0.8 mug/g wet weight in striatum tissue to 3.1 mug/g in frontal lobe. H-FABP was markedly higher, ranging from 16.2 mug/g wet weight in cerebellum tissue to 39.5 mug/g in pons. No B-FABP was detected in serum from healthy donors. H-FABP serum reference value was 6 mug/L. In the MTBI study, serum B-FABP was increased in 68% and H-FABP in 70% of patients compared with S100B (increased in 45%) and NSE (increased in 51% of patients). In ECT, serum B-FABP was increased in 6% of all samples (2 of 14 patients), whereas H-FABP was above its upper reference limit (6 mug/L) in 17% of all samples (8 of 14 patients), and S100B was above its upper reference limit (0.3 mug/L) in 0.4% of all samples. Conclusions: B-FABP and H-FABP patterns differ among brain tissues, with the highest concentrations in the frontal lobe and pons, respectively. However, in each part of the brain, the H-FABP concentration was at least 10 times higher than that of B-FABP. Patient studies indicate that B-FABP and H-FABP are more sensitive markers for minor brain injury than the currently used markers S100B and NSE.
Original languageEnglish
Pages (from-to)1568-1575
JournalClinical Chemistry
Volume50
DOIs
Publication statusPublished - 1 Jan 2004

Cite this